Excellent leukemia control after second hematopoietic cell transplants with unrelated cord blood grafts for post-transplant relapse in pediatric patients
A. Lucas(Memorial Sloan Kettering Cancer Center), Andromachi Scaradavou(NewYork–Presbyterian Hospital), Elizabeth Klein(Memorial Sloan Kettering Cancer Center), Caroline A. Lindemans(University Medical Center Utrecht), Susan E. Prockop(Memorial Sloan Kettering Cancer Center), Kevin J. Curran(Memorial Sloan Kettering Cancer Center), Birgitta Versluys(University Medical Center Utrecht), Jaap Jan Boelens(Wilhelmina Children's Hospital), Dorine Bresters(Willem-Alexander Kinderziekenhuis), Wouter J.W. Kollen(Princess Máxima Center), Nancy A. Kernan(Memorial Sloan Kettering Cancer Center), Marc Bierings(University Medical Center Utrecht), Eric Davis(Memorial Sloan Kettering Cancer Center), Anne Archer(Memorial Sloan Kettering Cancer Center)
Cited by 7
Related Papers
ASTCT Consensus Grading for Cytokine Release Syndrome and Neurologic Toxicity Associated with Immune Effector Cells
|Transplantation and Cellular Therapy|2018|3.6k
Efficacy and Toxicity Management of 19-28z CAR T Cell Therapy in B Cell Acute Lymphoblastic Leukemia
|Science Translational Medicine|2014|2.5k
Analysis of 462 Transplantations from Unrelated Donors Facilitated by the National Marrow Donor Program
|New England Journal of Medicine|1993|848